Dr. Paul cited government statistics suggesting that only about a third of the roughly 12 million Americans with serious depression are receiving treatment.

"Anything that confuses the appropriate use of Prozac or any of the antidepressants in the mind of the public might scare people away from using the medication, or perhaps even scare physicians from prescribing it," said Steven Paul, the Lilly vice president in charge of central nervous-system research.

